Contessa Health, now part of Amedisys, is a healthcare company that partners with health systems and physician groups to deliver hospital-level care in patients' homes. Their model, known as Home Recovery Care, aims to improve patient outcomes and experiences while reducing the cost of care. Contessa provides a comprehensive platform including clinical protocols, proprietary technology, and a dedicated care team to manage acutely ill patients who would otherwise be hospitalized. They also offer palliative care services (Palliative Care at Home) to support patients with serious illnesses. The acquisition by Amedisys in 2021 has expanded their reach and integrated their services into a broader continuum of home-based care.
The headquarters serves as the central operational and strategic command for developing and managing partnerships, clinical programs, technology development, and administrative functions.
The office is situated in a modern business park, likely designed to facilitate collaboration among its diverse teams, including clinical, technology, and business development professionals.
The work culture is described as mission-driven, innovative, and patient-focused, emphasizing teamwork and a commitment to transforming healthcare delivery to be more patient-centric and efficient.
Nashville's vibrant healthcare ecosystem provides Contessa Health with access to talent, potential partners, and a supportive environment for healthcare innovation.
Contessa Health's operations are primarily focused within the United States. As part of Amedisys, their services are being scaled across Amedisys's national footprint. There is no significant publicly disclosed information about current operations outside the U.S.
2002 Richard Jones Rd, Suite 304B
Nashville
TN
USA
Address: N/A - Operations are often co-located or closely integrated with partner health systems nationally.
To support the implementation and ongoing management of at-home care programs in collaboration with local hospitals and physician groups across different states.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Contessa Health' leadership includes:
Contessa Health has been backed by several prominent investors over the years, including:
Following the acquisition by Amedisys in mid-2021, Contessa Health's leadership was integrated into Amedisys. Major standalone executive changes for 'Contessa Health' as an independent entity are less frequent. Most senior leadership roles are now part of the broader Amedisys structure, particularly its Hospital at Home division. Information on specific hires/exits solely for the Contessa-branded unit in the last 12 months is not widely publicized.
Discover the tools Contessa Health uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Contessa Health, now part of Amedisys, likely utilizes email formats common in corporate environments, potentially including those specific to Contessa or aligned with Amedisys. A common format is [first_initial][last].
[first_initial][last]@contessahealth.com
Format
jdoe@contessahealth.com
Example
80%
Success rate
Amedisys • June 29, 2021
Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and personal care, announced the completion of its acquisition of Contessa Health, a leader in hospital at home and skilled nursing facility (SNF) at home services. This strategic acquisition positions Amedisys to offer a broader continuum of care in the home....more
Home Health Care News • February 22, 2024
Amedisys CEO Richard Ashworth stated that scaling Contessa Health, its hospital-at-home arm, is the company's highest priority for 2024. Despite current unprofitability for Contessa as it scales, Amedisys views it as a key future growth driver and is focused on expanding its partnerships and patient volume....more
Yahoo Finance (reporting Amedisys Q1 2024 Earnings) • May 1, 2024
Amedisys reported its first-quarter 2024 results, noting ongoing investments in its Contessa (high-acuity care) segment. While the segment saw increased admissions, it also incurred an EBITDA loss, reflecting the investment phase in scaling these services. The company remains focused on the long-term potential of its hospital-at-home offerings....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Contessa Health, are just a search away.